E + E Market Access Dossier
Achieving successful market access depends increasingly on communicating with stakeholders, such as key opinion leaders, scientific medical associations and health insurance companies. Contrary to the broad-communication approach used in classical pharmaceuticals marketing, communication is more specific here and must be centred on evidence-based medicine.
The Market Access Dossier is a tool that has been specifically developed to serve as a platform for discussions with stakeholders and it helps pharmaceuticals manufacturers to demonstrate the nature of their products in a convincing manner. It contains all of the facts and figures relevant to a pharmaceutical or medicinal product in a well-structured fashion, thus making these readily available for use in discussions.
Hence, the dossier is also a flexible presentation medium that can be used by field staff working in the area of health policy as well as for internal staff trainings.
The Market Access Dossier deals with the following subjects in line with the requirements of evidence-based medicine:
- comprehensive background on the disease and indication
- description of the current German and international guidelines and HTA
- comprehensive outline of statements of pharmaceutical evaluators
- description of pharmaceutics and pharmacology
- summary of results of clinical trials
- analysis of systematic reviews and meta-analyses
- details of therapy costs, cost-effectiveness analyses and budget impact analyses
- analysis of the care situation for the disease
The Market Access Dossier is a Powerpoint or PDF application with the following outstanding characteristics:
- full and clear navigation
- access to all relevant original documents
- adaptation of content to customer requirements
- design in accordance with corporate identity patterns
- cross-platform application for iPad, notebook, PC or Android tablet
Please contact
Dr. Christof Ecker
Phone +49 (40) 41 33 081-13